1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Jiangsu gdk Biotechnology Co., Ltd.

Jiangsu gdk Biotechnology Co., Ltd.

688670.SS
Jiangsu gdk Biotechnology Co., Ltd.CN flagShanghai Stock Exchange
15.67
CNY
-0.83
- -
1.93BMarket Cap

Total Valuation

Jiangsu gdk Biotechnology Co., Ltd. carries a market capitalization of 1.93B, placing it among publicly traded companies globally. Its enterprise value stands at 1.59B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.93B
Enterprise Value1.59B

Share Statistics

Jiangsu gdk Biotechnology Co., Ltd. currently has 123.20M shares outstanding.

Shares Outstanding123.20M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 21.62, and the price-to-book ratio stands at 18.38.

PE RatioN/A
PS Ratio21.62
PB Ratio18.38
P/TBV Ratio1.51
P/FCF Ratio40.84
P/OCF RatioN/A

Enterprise Valuation

EV / Sales19.62
EV / EBITDAN/A
EV / EBITN/A
EV / FCF36.21

Financial Position

Jiangsu gdk Biotechnology Co., Ltd. maintains a current ratio of 2.43, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.66, indicating elevated leverage, while an interest coverage ratio of -75.28 demonstrates limited ability to service its debt obligations.

Current Ratio2.43
Quick Ratio1.06
Debt / Equity4.66
Debt / EBITDA-0.59
Interest Coverage-75.28

Financial Efficiency

Return on Equity (ROE)-65.25
Return on Assets (ROA)-6.12
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.42

Taxes

Income Tax-25.68M
Effective Tax RateN/A

Stock Price Statistics

Jiangsu gdk Biotechnology Co., Ltd.'s stock has gained approximately 12.00858% over the past 52 weeks. The 50-day moving average sits at 16.94, while the 200-day moving average is 19.16.

Beta (5Y)N/A
52-Week Price Change12.00858%
50-Day Moving Average16.94
200-Day Moving Average19.16
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Jiangsu gdk Biotechnology Co., Ltd. generated 81.04M in revenue and converted that into -92.29M in net income, yielding earnings per share of -0.73. EBITDA reached -97.44M, while operating income came in at -97.44M.

Revenue81.04M
Gross Profit51.37M
Operating Income-97.44M
Pretax Income-117.96M
Net Income-92.29M
EBITDA-97.44M
EBIT-97.44M
Earnings Per Share (EPS)-0.73

Balance Sheet

Jiangsu gdk Biotechnology Co., Ltd. holds 219.31M in cash and equivalents against 57.64M in total debt, resulting in a net debt position of -16.77M. Total book value stands at 95.29M, with working capital of 295.19M providing operational flexibility.

Cash & Cash Equivalents219.31M
Total Debt57.64M
Net Debt-16.77M
Equity (Book Value)95.29M
Book Value Per Share0.76
Working Capital295.19M

Cash Flow

After subtracting -42.90M in capital expenditures, free cash flow totaled -42.90M - equivalent to -0.34 per share.

Operating Cash FlowN/A
Capital Expenditures-42.90M
Free Cash Flow-42.90M
FCF Per Share-0.34

Margins

Jiangsu gdk Biotechnology Co., Ltd. operates with a gross margin of 63.39, reflecting its pricing power and cost economics. The operating margin of -120.24 and net profit margin of -113.88 provide insight into operational efficiency.

Gross Margin63.39
Operating Margin-120.24
Pretax Margin-145.57
Profit Margin-113.88
EBITDA Margin-120.24

Dividends & Yields

The company's payout ratio of -1.41 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.01
Dividend YieldN/A
Payout Ratio-1.41
Shareholder Yield0.05
FCF Yield2.45

Stock Splits

Jiangsu gdk Biotechnology Co., Ltd.'s most recent stock split took place on May 26, 2023 with a 5:7 split ratio.

Last Split Date5/26/2023
Split Ratio5:7

Scores

Jiangsu gdk Biotechnology Co., Ltd. posts an Altman Z-Score of 4.47, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.47